A Synergistic Anti-Cancer Effect of Troglitazone and Lovastatin in a Human Anaplastic Thyroid Cancer Cell Line and in a Mouse Xenograft Model
出版年份 2018 全文链接
标题
A Synergistic Anti-Cancer Effect of Troglitazone and Lovastatin in a Human Anaplastic Thyroid Cancer Cell Line and in a Mouse Xenograft Model
作者
关键词
-
出版物
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 19, Issue 7, Pages 1834
出版商
MDPI AG
发表日期
2018-06-22
DOI
10.3390/ijms19071834
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Realizing drug repositioning by adapting a recommendation system to handle the process
- (2018) Makbule Guclin Ozsoy et al. BMC BIOINFORMATICS
- Anaplastic thyroid carcinoma: review of treatment protocols
- (2018) Vera Tiedje et al. ENDOCRINE-RELATED CANCER
- Lipid lowering agents of natural origin: An account of some promising chemotypes
- (2017) Suriya P. Singh et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Survival in Response to Multimodal Therapy in Anaplastic Thyroid Cancer
- (2017) Naiyarat Prasongsook et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Correction: Combined Treatment with Troglitazone and Lovastatin Inhibited Epidermal Growth Factor-Induced Migration through the Downregulation of Cysteine-Rich Protein 61 in Human Anaplastic Thyroid Cancer Cells
- (2017) Li-Han Chin et al. PLoS One
- Protective Effects of Statins in Cancer: Should They Be Prescribed for High-Risk Patients?
- (2016) Ange Wang et al. Current Atherosclerosis Reports
- Peroxisome proliferator-activated receptors (PPARs) and PPAR agonists: the ‘future’ in dermatology therapeutics?
- (2015) Mrinal Gupta et al. ARCHIVES OF DERMATOLOGICAL RESEARCH
- Effects of Thiazolidinediones on metabolism and cancer: Relative influence of PPARγ and IGF-1 signaling
- (2015) Amreen Mughal et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Involvement of cysteine-rich protein 61 in the epidermal growth factor-induced migration of human anaplastic thyroid cancer cells
- (2015) Li-Han Chin et al. MOLECULAR CARCINOGENESIS
- Chemotherapy and Chemoprevention by Thiazolidinediones
- (2015) Eleonore Fröhlich et al. Biomed Research International
- Anaplastic Thyroid Carcinoma: A 25-year Single-Institution Experience
- (2014) A. Mohebati et al. ANNALS OF SURGICAL ONCOLOGY
- Peroxisome proliferator-activated receptors and their ligands: nutritional and clinical implications - a review
- (2014) Bogna Grygiel-Górniak Nutrition Journal
- Targeting the ABCG2-overexpressing multidrug resistant (MDR) cancer cells by PPARγ agonists
- (2013) Kenneth K W To et al. BRITISH JOURNAL OF PHARMACOLOGY
- Super-radical surgery for anaplastic thyroid carcinoma: A large cohort study using the anaplastic thyroid carcinoma research consortium of Japan database
- (2013) Iwao Sugitani et al. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK
- A comparative study of cell cycle mediator protein expression patterns in anaplastic and papillary thyroid carcinoma
- (2012) Juanita J. Evans et al. CANCER BIOLOGY & THERAPY
- Lovastatin inhibits proliferation of anaplastic thyroid cancer cells through up-regulation of p27 by interfering with the Rho/ROCK-mediated pathway
- (2011) Wen-Bin Zhong et al. BIOCHEMICAL PHARMACOLOGY
- PPAR gamma, bioactive lipids, and cancer progression
- (2011) Gregory et al. Frontiers in Bioscience-Landmark
- In vivoevidence of duality effects for lovastatin in a nude mouse cancer model
- (2009) Chih-Yuan Wang et al. INTERNATIONAL JOURNAL OF CANCER
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started